Ravi Vij, MD, MBA

Ravi Vij, MD, MBA


Division of Oncology
Mail Stop 8007-0029-11
Washington University
660 South Euclid Avenue
St. Louis, MO 63110

11th Floor Mid Campus Center (office)

Tanya Cuso

Research Interests
  • Stem cell transplantation for hematologic malignancy
  • Multiple myeloma
  • Acute myeloid leukemia/myelodysplastic syndromes

My area of academic pursuit is the treatment of hematologic malignancies and hematopoietic stem cell transplantation. I serve on the Core Transplant, Myeloma and Leukemia Committees of the CALGB, the Myeloma Committee of the BMT Clinical Trials Network (CTN) and the Multiple Myeloma Cancer Immunotherapy Guideline Panel of the Society for Immunotherapy of Cancer. I have served on the American Society of Clinical Oncology and the American Society of Hematology Scientific Committees on Plasma Cell Dyscrasias. I have served as principal investigator on several national and institutional clinical trials looking at strategies to improve the outcome of patients with multiple myeloma, acute myeloid leukemia and myelodysplastic syndromes and played a role in the development of drugs approved for Multiple Myeloma and oversee an active clinical research program in multiple myeloma. As Principal Investigator for the Multiple Myeloma Tissue Banking Initiative, I work closely with basic scientists both within and outside the institution to study the genomics and biology of the disease and harness the knowledge to foster better therapeutic options including a number of personalized medicine and immunotherapy initiatives for treatment of multiple myeloma including studies with CAR-T cells and T cell engagers.



  • 2013-2012: Healthcare MBA, George Washington University
  • 1989: MBBS, Maulana Azad Medical College, University of Delhi, New Delhi, India

Post-Graduate Training

  • 2000-1999: Fellowship, Bone Marrow Transplantation//Malignant Hematology/Stem Cell Biology, Washington University, St. Louis, MO
  • 1999-1996: Fellowship, Medical Oncology/Hematology, Washington University, St. Louis, MO
  • 1996-1993: Residency, Internal Medicine, Rush Presbyterian St. Luke’s Medical Center, Chicago, IL
  • 1993-1992: Senior House Officer, Halifax General Hospital and Royal Infirmary, Halifax, West Yorkshire, UK
  • 1990: Rotating Internship, Lok Nayak Jayaprakash Narayan & G.B. Pant Hospitals, New Delhi, India

Academic Positions

  • present-2016: Medical Director, Siteman Cancer Center, Barnes West County Hospital, Barnes St. Peter’s Hospital, South County Satellite
  • present-2015: Professor of Medicine, Section of Bone Marrow Transplantation & Leukemia, Washington University School of Medicine, St. Louis, MO
  • 2015-2007: Associate Professor of Medicine, Section of Bone Marrow Transplantation & Leukemia, Washington University School of Medicine, St. Louis, MO
  • 2007-2004: Assistant Professor of Medicine, Section of Bone Marrow Transplantation & Leukemia, Washington University School of Medicine, St. Louis, MO
  • 2004-2001: Staff Physician, Section of Hematology/Oncology, John Cochran VA Medical Center, St. Louis, MO
  • 2004-2000: Instructor in Medicine, Section of Bone Marrow Transplantation & Leukemia, Washington University School of Medicine, St. Louis, MO

Board Certification

  • 2010, 2000: Hematology
  • 2008, 1999: Oncology
  • 2006, 1996: Internal medicine

Honors & Awards

  • 2017: Multiple Myeloma Reasearch Foundation Collaborator Award
  • 2014-2005: Listed in Best Doctors in America (Best Doctors, Inc.)
  • 2013: Multiple Myeloma Reasearch Foundation Innovator Award
  • 2011: Chair, Race for Multiple Myeloma
  • 2011: Multiple Myeloma Research Consortium Center of Excellence Award
  • 2010: Honoree, BJC Foundation Cancer Frontier Fund Charity Gala
  • 2008: Honoree, Multiple Myeloma Laugh for Life (MMRF)
  • 2008: Honoree, CUREiosity (Siteman Cancer Center Charity Gala)
  • 2007: Teacher of the year (Hematology/Oncology Fellowship Program)
  • 1999: Amgen Fellows Scholarship
  • 1998: AACR/ASCO Clinical Cancer Research Scholar

Professional Societies

  • American Society of Clinical Oncology
  • American Society of Hematology
  • American Society of Bone Marrow Transplantation

Extramural Committees

  • present-2022: ASCO Scientific Committee
  • present-2013: CTN Myeloma Committee
  • present-2011: CALGB Myeloma Committee
  • present-2011: CALGB Leukemia Committee
  • present-2011: Multiple Myeloma Research Consortium (MMRC) Steering Committee
  • present-2006: CALGB Core Transplant Committee
  • 2019-2016: ASH Scientific Committee on Plasma Cell Neoplasia
  • 2018-2015: ASCO Education Committee
  • 2015-2014: Scholar Selection Committee (Alliance for Clinical Trials in Oncology Foundation)
  • 2010-2006: NCCN Anemia Guidelines Committee

Intramural Committees

  • present-2017: BJH High Cost Medication Committee
  • present -2015:Siteman Investment Program Study Section
  • present-2014: K12 Paul Calabresi Career Development Awards Program Review Committee
  • present-2013: Washington University Heme-Onc Fellowship Clinical Competency Committee
  • present-2007: Washington University Hematology-Oncology Fellowship Committee
  • 2005-2004: Transfusion Committee, Barnes-Jewish Hospital
  • 2005-2002: Protocol Review and Monitoring Committee, Siteman Cancer Center
  • 2004-2002: Performance Improvement Committee, John Cochran VA Medical Center

Other Responsibilities

  • present-2014: Multiple Myeloma Steering Committee: Medscape
  • present-2008: Safety Oversight Group, Carfilzomib-003 Study (Proteolix)
  • 2021, 2016: ICER report on Myeloma: Faculty Advisor
  • 2011-2009: DSMB, VANTAGE 88 and 95 Trials (Merck)
  • 2014-2012: DSMB, Phase 2/3 Study of Tabalumab + Bortezomib and Dexamethasone (Eli Lilly)
    • Steering Committee, PREAMBLE Study (Bristol Meyer Squibb)
    • Steering Committee, COMPASS Study (MMRF)
  • 2006-2005: MDS Treatment Resource Center, NMCR